Physician profile
Jarrett A Johnson
NPI 1174540629
$2,320.06
in general payments reported to CMS, 2019-2025
13 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $241 · 2021: $796 · 2022: $325 · 2023: $284 · 2024: $249 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $879.07 | 2019-2025 | Acuvue |
| Dompe US, INC. | $249.98 | 2023-2024 | Oxervate |
| Optos, INC. | $191.18 | 2022 | |
| Alcon Vision LLC | $174.23 | 2020-2025 | Precision7 |
| Coopervision INC. | $139.29 | 2022-2024 | Myday Contact Lens |
| Glaukos Corporation | $138.94 | 2021-2023 | |
| Biotissue Holdings INC. | $127.04 | 2025 | |
| Kala Pharmaceuticals, INC. | $121.52 | 2021 | |
| Rxsight INC | $104.52 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $74.81 | 2025 | Xdemvy |
| Genentech USA, INC. | $59.07 | 2019 | |
| Shire North American Group INC | $46.95 | 2019 | |
| Allergan, INC. | $13.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarrett Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.